Strides Shasun inks JV pact with Vivimed Labs
The first 50:50 joint venture company in India will own a USFDA approved formulation facility in Alathur, Chennai, Strides Shasun said in a regulatory filing.
By PTI |
NEW DELHI: Drug firm Strides Shasun today said it has inked a pact with Vivimed Labs to set up two joint venture firms.
The first JV -- a 50:50 joint venture company in India will own a USFDA approved formulation facility in Alathur, Chennai, Strides Shasun said in a regulatory filing.
The second JV firm would come up in Singapore and will own various approved abbreviated new drug applications (ANDAs) and product pipeline, it added.
The exercise provides additional capacity and derisks manufacturing infrastructure, the company said.
The transaction is expected to close on May 31, 2017.
The first JV -- a 50:50 joint venture company in India will own a USFDA approved formulation facility in Alathur, Chennai, Strides Shasun said in a regulatory filing.
The second JV firm would come up in Singapore and will own various approved abbreviated new drug applications (ANDAs) and product pipeline, it added.
The exercise provides additional capacity and derisks manufacturing infrastructure, the company said.
The transaction is expected to close on May 31, 2017.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
